Scientific and Business Partners
FUJIFILM Cellular Dynamics, Inc. (FCDI) is a leading developer and manufacturer of
human induced pluripotent stem cells (hiPSCs) utilized in drug discovery and cell
therapies. FCDI offers life science research tools including the company’s inventoried
iCell® products that are available in many cell types and sourced from multiple cell lines which can be applied for target identification as well as toxicity testing. The company also offers custom cell development services and integrated drug discovery services with partners. FCDI’s goal is to leverage the vast utility of hiPSCs to advance human health and improve the quality of life for patients around the world.
Founded in 2015 as a spin-out from the Paul Scherrer Institute (ETH), leadXpro is located in Switzerland, between the pharma and science hubs of Basel and Zürich. leadXpro is revolutionising drug discovery for membrane proteins, targeting GPCRs, ion channels and transporters. These proteins represent more than half of clinically-used current drug targets, but remain the most difficult targets for structure-based drug design, due to the challenges in solving their atomic structures in complex with drug candidates. leadXpro combines state-of-the-art methods for membrane protein science, advanced biophysical methods to characterize drug candidate interactions and pioneering technologies in structural biology, including cryo-EM and time-resolved X-ray crystallography at SwissFEL.
Neuro-Zone S.r.l. is an innovation driven cell-based service company supporting drug
discovery, drug repurposing and research projects in the fields of inflammation and
age-related pathologies. Neuro-Zone aims to unveil the role of the microenvironment in complex disease scenarios through unique proprietary technological solutions, with the goal of easing lead efficacy assessment. Neuro-Zone activities enable collection of rapid and informative data on efficacy, toxicity, metabolism and mechanism of action. Moreover, they enable effective selection and ranking of the most promising candidates per indication.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s portfolio of over 4,000 products supports a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. For over 40 years these tools and technologies have grown in their application and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors.
Symeres is a leading European contract research organization for drug discovery and
development projects. Their services span from early-stage hit finding all the way to the delivery of Phase II API and customised in vitro and in vivo ADME-Tox packages.
The partnership between Symeres and Axxam gives our clients access to best-in-class
fully integrated drug discovery services, supported by a culture of scientific excellence, innovation and creativity.
ZoBio offers an integrated fragment-based drug discovery engine based on orthogonal technologies and 16 years of experience. Located in the Netherlands, ZoBio delivers the right small molecule for your target by combining its expertise in protein sciences, biophysical and biochemical assays, structural biology and medicinal chemistry.
Lombardy Life Sciences Cluster